GeneDx Holdings Corp. Capitalized Computer Software, Amortization
GeneDx Holdings Corp. (WGS) reported Capitalized Computer Software, Amortization of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CapitalizedComputerSoftwareAmortization1 · last filed 2026-02-23
- GeneDx Holdings Corp. capitalized computer software, amortization for the quarter ending 2023-12-31 was $700.00K, a 93.27% decline year-over-year.
- GeneDx Holdings Corp. capitalized computer software, amortization for the quarter ending 2023-09-30 was $200.00K, a 88.24% decline year-over-year.
- GeneDx Holdings Corp. capitalized computer software, amortization for the quarter ending 2023-06-30 was $4.70M, a 176.47% increase year-over-year.
- GeneDx Holdings Corp. capitalized computer software, amortization for the quarter ending 2023-03-31 was $1.00M, a 37.50% decline year-over-year.
- GeneDx Holdings Corp. capitalized computer software, amortization for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- GeneDx Holdings Corp. capitalized computer software, amortization for fiscal 2023 was $6.60M, a 57.14% decline from fiscal 2022.
- GeneDx Holdings Corp. capitalized computer software, amortization for fiscal 2022 was $15.40M, a 175.00% increase from fiscal 2021.
- GeneDx Holdings Corp. capitalized computer software, amortization for fiscal 2021 was $5.60M, a 86.67% increase from fiscal 2020.
| Period end | Capitalized Computer Software, Amortization 3 month | Capitalized Computer Software, Amortization 6 month | Capitalized Computer Software, Amortization 6 month as first filed | Capitalized Computer Software, Amortization 9 month | Capitalized Computer Software, Amortization 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-20 | ||||
| 2023-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $900.00K derived: sum of 2 quarters · filed 2026-02-23 | $5.60M derived: sum of 3 quarters · filed 2026-02-23 | $6.60M 10-K · filed 2026-02-23 | |
| 2023-09-30 | $200.00K 10-Q · filed 2023-11-03 | $4.90M derived: sum of 2 quarters · filed 2023-11-03 | $5.90M 10-Q · filed 2023-11-03 | $16.30M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2023-06-30 | $4.70M 10-Q · filed 2023-08-08 | $5.70M 10-Q · filed 2023-08-08 | $16.10M derived: sum of 3 quarters · filed 2024-02-23 | $17.80M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2023-03-31 | $1.00M 10-Q · filed 2023-05-09 | $11.40M derived: sum of 2 quarters · filed 2024-02-23 | $13.10M derived: sum of 3 quarters · filed 2024-02-23 | $14.80M derived: sum of 4 quarters · filed 2024-02-23 | |
| 2022-12-31 | $10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $12.10M derived: sum of 2 quarters · filed 2024-02-23 | $13.80M derived: sum of 3 quarters · filed 2024-02-23 | $15.40M 10-K · filed 2024-02-23 | |
| 2022-09-30 | $1.70M 10-Q · filed 2023-11-03 | $3.40M derived: sum of 2 quarters · filed 2023-11-03 | $5.00M 10-Q · filed 2023-11-03 | $6.60M derived: sum of 4 quarters · filed 2023-11-03 | |
| 2022-06-30 | $1.70M 10-Q · filed 2023-08-08 | $3.30M 10-Q · filed 2023-08-08 | $4.90M derived: sum of 3 quarters · filed 2023-08-08 | $6.30M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $1.60M 10-Q · filed 2023-05-09 | $3.20M derived: sum of 2 quarters · filed 2023-05-09 | $4.60M derived: sum of 3 quarters · filed 2023-05-09 | $6.00M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.00M derived: sum of 2 quarters · filed 2023-03-16 | $4.40M derived: sum of 3 quarters · filed 2023-03-16 | $5.60M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $1.40M 10-Q · filed 2022-11-14 | $2.80M derived: sum of 2 quarters · filed 2022-11-14 | $4.00M 10-Q · filed 2022-11-14 | $5.00M derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-06-30 | $1.40M 10-Q · filed 2022-08-15 | $2.60M 10-Q · filed 2022-08-15 | $1.40M 10-Q · filed 2021-11-15 | $3.60M derived: sum of 3 quarters · filed 2023-03-16 | $4.80M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $1.20M 10-Q · filed 2022-05-12 | $2.20M derived: sum of 2 quarters · filed 2023-03-16 | $3.40M derived: sum of 3 quarters · filed 2023-03-16 | ||
| 2020-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $2.20M derived: sum of 2 quarters · filed 2023-03-16 | $3.00M 10-K · filed 2023-03-16 | ||
| 2020-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $2.00M 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $800.00K 10-Q · filed 2021-11-15 | ||||
| 2019-12-31 | $1.20M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |